Literature DB >> 11344187

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.

C Weyer1, T Funahashi, S Tanaka, K Hotta, Y Matsuzawa, R E Pratley, P A Tataranni.   

Abstract

Plasma concentrations of adiponectin, a novel adipose-specific protein with putative antiatherogenic and antiinflammatory effects, were found to be decreased in Japanese individuals with obesity, type 2 diabetes, and cardiovascular disease, conditions commonly associated with insulin resistance and hyperinsulinemia. To further characterize the relationship between adiponectinemia and adiposity, insulin sensitivity, insulinemia, and glucose tolerance, we measured plasma adiponectin concentrations, body composition (dual-energy x-ray absorptiometry), insulin sensitivity (M, hyperinsulinemic clamp), and glucose tolerance (75-g oral glucose tolerance test) in 23 Caucasians and 121 Pima Indians, a population with a high propensity for obesity and type 2 diabetes. Plasma adiponectin concentration was negatively correlated with percent body fat (r = -0.43), waist-to-thigh ratio (r = -0.46), fasting plasma insulin concentration (r = -0.63), and 2-h glucose concentration (r = -0.38), and positively correlated with M (r = 0.59) (all P < 0.001); all relations were evident in both ethnic groups. In a multivariate analysis, fasting plasma insulin concentration, M, and waist-to-thigh ratio, but not percent body fat or 2-h glucose concentration, were significant independent determinates of adiponectinemia, explaining 47% of the variance (r(2) = 0.47). Differences in adiponectinemia between Pima Indians and Caucasians (7.2 +/- 2.6 vs. 10.2 +/- 4.3 microg/ml, P < 0.0001) and between Pima Indians with normal, impaired, and diabetic glucose tolerance (7.5 +/- 2.7, 6.1 +/- 2.0, 5.5 +/- 1.6 microg/ml, P < 0.0001) remained significant after adjustment for adiposity, but not after additional adjustment for M or fasting insulin concentration. These results confirm that obesity and type 2 diabetes are associated with low plasma adiponectin concentrations in different ethnic groups and indicate that the degree of hypoadiponectinemia is more closely related to the degree of insulin resistance and hyperinsulinemia than to the degree of adiposity and glucose intolerance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11344187     DOI: 10.1210/jcem.86.5.7463

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  824 in total

1.  Adipokine concentrations in nonobese women: a study of reproductive aging, body mass index, and menstrual cycle effects.

Authors:  Patricia A Rouen; Jane L Lukacs; Nancy E Reame
Journal:  Biol Res Nurs       Date:  2010-05-07       Impact factor: 2.522

2.  Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women.

Authors:  George A King; Sarah E Deemer; Dixie L Thompson
Journal:  Acta Diabetol       Date:  2010-05-08       Impact factor: 4.280

3.  Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

Authors:  Debora Macis; Sara Gandini; Aliana Guerrieri-Gonzaga; Harriet Johansson; Paolo Magni; Massimiliano Ruscica; Matteo Lazzeroni; Davide Serrano; Massimiliano Cazzaniga; Serena Mora; Irene Feroce; Maria Pizzamiglio; Maria Teresa Sandri; Marcella Gulisano; Bernardo Bonanni; Andrea Decensi
Journal:  J Clin Oncol       Date:  2011-12-12       Impact factor: 44.544

Review 4.  Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10?

Authors:  Dick C Chan; Jing Pang; Gerald F Watts
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

Review 5.  Beyond the bone: Bone morphogenetic protein signaling in adipose tissue.

Authors:  Ana M Blázquez-Medela; Medet Jumabay; Kristina I Boström
Journal:  Obes Rev       Date:  2019-01-04       Impact factor: 9.213

Review 6.  Obesity, energy balance, and cancer: new opportunities for prevention.

Authors:  Stephen D Hursting; John Digiovanni; Andrew J Dannenberg; Maria Azrad; Derek Leroith; Wendy Demark-Wahnefried; Madhuri Kakarala; Angela Brodie; Nathan A Berger
Journal:  Cancer Prev Res (Phila)       Date:  2012-10-03

Review 7.  The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications.

Authors:  Oliver P Flint; Mustafa A Noor; Paul W Hruz; Phil B Hylemon; Kevin Yarasheski; Donald P Kotler; Rex A Parker; Aouatef Bellamine
Journal:  Toxicol Pathol       Date:  2009-01-26       Impact factor: 1.902

8.  Adiponectin as predictor for diabetes among pre-diabetic groups.

Authors:  Hyon-Suk Kim; Jaeseong Jo; Jung Eun Lim; Young Duk Yun; Soo Jin Baek; Tae-Yong Lee; Kap Bum Huh; Sun Ha Jee
Journal:  Endocrine       Date:  2013-02-06       Impact factor: 3.633

Review 9.  Implications of adiponectin in linking metabolism to testicular function.

Authors:  Luc J Martin
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

10.  ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study.

Authors:  Daruneewan Warodomwichit; Jian Shen; Donna K Arnett; Michael Y Tsai; Edmond K Kabagambe; James M Peacock; James E Hixson; Robert J Straka; Michael A Province; Ping An; Chao-Qiang Lai; Laurence D Parnell; Ingrid B Borecki; Jose M Ordovas
Journal:  Obesity (Silver Spring)       Date:  2008-12-18       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.